1例疑似头孢曲松致儿童药物性肝损伤的药学监护  

Pharmaceutical Care for a Child with Suspected Drug-Induced Liver Injury Induced by Ceftriaxone

作　　者：姜辰[1] 翁小红[2] 赵凯[2] 邵思超 Jiang Chen;Weng Xiaohong;Zhao Kai;Shao Sichao(Wuxi Children's Hospital,Jiangsu Wuxi 214023,China;Municipal Hospital of Suzhou,Jiangsu Suzhou 215002,China)

机构地区：[1]无锡市儿童医院,江苏无锡214023 [2]苏州市立医院,江苏苏州215002

出　　处：《儿科药学杂志》2021年第6期44-46,共3页Journal of Pediatric Pharmacy

摘　　要：目的:探讨疑似头孢曲松致儿童药物性肝损伤的干预措施,提高临床药师的药学监护水平。方法:对1例疑似头孢曲松致儿童药物性肝损伤的病例进行分析与讨论,并复习相关文献。结果:患儿疑似为使用头孢曲松后出现了轻度肝损伤,予以停用头孢曲松并保肝治疗后逐渐好转。结论:临床药师需要加强对药物性肝损伤的关注,如果出现药物性肝损伤需要及时评估,协同医师共同完成患儿的治疗。Objective:To probe into the intervention measures of suspected drug-induced liver injury induced by ceftriaxone in children,and improve the level of pharmaceutical care of clinical pharmacists.Methods:A child with suspected drug-related liver injury induced by ceftriaxone was analyzed and discussed,and the relevant literature was reviewed.Results:The child was suspected to have developed mild liver injury after ceftriaxone application,and the condition was improved after ceftriaxone discontinuation and liver-protective treatment.Conclusion:Clinical pharmacists should pay more attention to drug-induced liver injury,and cooperate with the clinicians to complete the treatment if timely evaluation is needed.

关 键 词：药物性肝损伤 儿童 头孢曲松 药学监护 

分 类 号：R969.3[医药卫生—药理学]